SCHEMBL15966916

SCHEMBL15966916

CSc1ncc2nc(-c3ccccc3)oc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.43
NTRK1 P04629 1/20 0.42
HPGD P15428 4/20 0.41
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CASP3 P42574 2/20 0.41
RAB9A P51151 2/20 0.41
SENP7 Q9BQF6 2/20 0.41
SENP6 Q9GZR1 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
SENP8 Q96LD8 1/20 0.41
ELANE P08246 1/20 0.41
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ACACB O00763 2/20 0.39
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15966899 0.84 F7 (0.44) MAOBHPGDKDM4ESMN1; SMN2CASP3
SCHEMBL9932139 0.76 SMN1; SMN2 (0.47) MAOBHPGDKDM4ESMN1; SMN2CASP3
SCHEMBL2224907 0.75 S1PR1 (0.42) HPGDKDM4ESMN1; SMN2RAB9ANPC1
SCHEMBL11645943 0.69 RAB9A (0.58) MAOBHPGDKDM4ESMN1; SMN2CASP3
SCHEMBL23877677 0.69 MAOB (0.47) MAOBNTRK1KDM4ESMN1; SMN2RAB9A
SCHEMBL18310041 0.68 NTRK1 (0.56) NTRK1KDM4EPOLBMEN1KMT2A
SCHEMBL11642499 0.67 MAOB (0.56) MAOBHPGDKDM4ESMN1; SMN2CASP3
SCHEMBL9867688 0.67 SGMS2 (0.55) MAOBHPGDKDM4ESMN1; SMN2CASP3
SCHEMBL6885681 0.67 RAB9A (0.54) NTRK1HPGDKDM4ESMN1; SMN2RAB9A
SCHEMBL14650242 0.67 NPC1 (0.50) MAOBHPGDKDM4ESMN1; SMN2CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523963-B1 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES AS EDG-1 AGONISTS SANOFI SA (FR) 2014-08-27 EP disclosed